Last checked at Motif Bio Raises GBP650,000 To Strengthen Cash Position
Motif Bio Raises GBP650,000 To Strengthen Cash Position
5 May 20 10:58
- Home
- Share Prices
- NEX Exchange Share Prices
- Share Chat
- FX
- News
- Blogs
- RNS
- Media
- Trading
- Finance Tools
- Members
Latest Share Chat
Motif Bio Share News (MTFB)
MTFB Share
Price
MTFB Share
News
MTFB Share
Chat35
MTFB Share
Trades107
MTFB
Live RNS
MTFB Share
Charts
MTFB Level 2
Console
MTFB Live
Share Price
MTFB Broker
Ratings
MTFB Directors
Deals
MTFB Financial
Diary
MTFB
Fundamentals
MTFB Short
Positions
MTFB
Media
MTFB Information
Share Price Information for Motif Bio (MTFB)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
0.60
Bid:
0.56
Ask:
0.70
Change:
-0.0615
(-9.30%)
Spread:
0.14 (25.00%)
Open:
0.601
High:
0.65
Low:
0.58
Yest. Close:
0.6615
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.5 May 20 10:58Motif Bio raises ?0.65m as it hunts for reverse takeover opportunity
(Sharecast News) - Motif Bio, which has been reclassified as an AIM rule 15 cash shell, has raised a total of ?0.65m before expenses via a placing, it announced on Tuesday, through the issue of 162,500,000 ordinary shares with an institutional investor at a price of 0.4p each.
5 May 20 09:17UK EXECUTIVE CHANGE SUMMARY: Scapa Healthcare, Industrial Heads Resign
UK EXECUTIVE CHANGE SUMMARY: Scapa Healthcare, Industrial Heads Resign
4 May 20 15:42Motif Bio Notes Hike In Share Price, Still Waiting For Sale Of Assets
Motif Bio Notes Hike In Share Price, Still Waiting For Sale Of Assets
14 Apr 20 17:12Motif Bio Still Seeks To Make Acquisition As Working Capital Dwindles
Motif Bio Still Seeks To Make Acquisition As Working Capital Dwindles
19 Mar 20 14:51Motif Bio struggling to find reverse takeover opportunity
(Sharecast News) - Motif Bio updated the market on its corporate developments on Wednesday, having been reclassified as an AIM rule 15 cash shell.
18 Mar 20 15:33Motif Bio And Hercules Amend Agreement To Facilitate Iclaprim Sale
Motif Bio And Hercules Amend Agreement To Facilitate Iclaprim Sale
28 Jan 20 11:31Motif Bio To De-List From Nasdaq, Last Day Of Trading December 16
Motif Bio To De-List From Nasdaq, Last Day Of Trading December 16
26 Nov 19 18:15Five Motif Bio Non-Executive Directors Leave As Part Of Restructuring
Five Motif Bio Non-Executive Directors Leave As Part Of Restructuring
18 Nov 19 13:50Motif Bio Seals Clinical Research Firm Settlement Without Payments
Motif Bio Seals Clinical Research Firm Settlement Without Payments
11 Nov 19 09:52Motif Bio reaches settlement with former clinical research organisation
(Sharecast News) - Motif Bio announced on Monday that its subsidiary Motif BioSciences has reached an agreement with its former clinical research organisation to settle all obligations without further payment.
11 Nov 19 09:40Invesco Cuts Stake In Biopharmaceutifcal Firm Motif Bio To 8.4%
Invesco Cuts Stake In Biopharmaceutifcal Firm Motif Bio To 8.4%
25 Oct 19 17:34Motif Bio announces US Army-funded evaluation of 'iclaprim'
(Sharecast News) - Clinical-stage biopharmaceutical company Motif Bio has signed an agreement with the Walter Reed Army Institute of Research (WRAIR) to conduct pre-clinical testing to evaluate novel combinations with 'iclaprim', to improve safety and efficacy administered by a novel enhanced aerosol technology, it announced on Thursday.
24 Oct 19 16:05Motif Bio Teams Up With US Forces To Look Into Iclaprim Use
Motif Bio Teams Up With US Forces To Look Into Iclaprim Use
24 Oct 19 12:01UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped
UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped
24 Oct 19 10:31